The epstein-barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells
- 9 July 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 48 (5), 794-800
- https://doi.org/10.1002/ijc.2910480527
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte culturesEuropean Journal of Immunology, 1990
- Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virusNature, 1990
- Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiationNature, 1990
- An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).The Journal of Experimental Medicine, 1990
- Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.Proceedings of the National Academy of Sciences, 1988
- Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinomaInternational Journal of Cancer, 1988
- Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.The Journal of Experimental Medicine, 1988
- The Epstein-Barr Virus ProteinsAdvances in Cancer Research, 1988
- High-efficiency transformation of mammalian cells by plasmid DNA.Molecular and Cellular Biology, 1987
- Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12.Proceedings of the National Academy of Sciences, 1979